Chettinad Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 2.50 M
as on 12-12-2024
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Chettinad Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Perumal and Muthukrishnan Veerasekaran serve as directors at the Company.
- CIN/LLPIN
U24231TN2004PTC150369
- Company No.
264470
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2004
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Chettinad Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Perumal  | Director | 21-Sep-2019 | Current |
| Muthukrishnan Veerasekaran | Director | 16-Jan-2014 | Current |
Financial Performance of Chettinad Pharmaceuticals.
Chettinad Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chettinad Pharmaceuticals?
In 2017, Chettinad Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chettinad E-Publishing Private LimitedActive 20 years 1 monthGopal Perumal and Muthukrishnan Veerasekaran are mutual person
- Chettinad Electronics Private LimitedActive 20 years 1 month
Gopal Perumal and Muthukrishnan Veerasekaran are mutual person
- Chettinad Trucks & Equipments Private LimitedActive 19 years 10 months
Gopal Perumal and Muthukrishnan Veerasekaran are mutual person
- Chettinad Packers And Movers Private LimitedActive 17 years 9 months
Gopal Perumal and Muthukrishnan Veerasekaran are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chettinad Pharmaceuticals?
Unlock and access historical data on people associated with Chettinad Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chettinad Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chettinad Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
